Jump to section
To enable organizations to thrive ethically and responsibly with smart and safe synthetic data.
Synthetic data is information that is artificially manufactured and not actually created by real-world activities and events. That’s important because developing AI and ML (machine learning) projects require immense amounts of data. However, real-world data can be expensive and difficult to collect.
MOSTLY AI uses artificial intelligence to achieve a high degree of fidelity to its clients’ databases. Its data sets look just as real as a company’s original customer data with just as many details, but without the original personal data points. Unlike some of its competitors, MOSTLY AI hasn’t put its focus on healthcare, instead winning clients amongst Fortune 100 companies and major Telcos.
The startup is focused on international hires and geographic expansion, especially in the U.S. To do so, it is expanding its team there significantly and leveraging the connections of its latest investor - the venture arm of American Bank, CitiGroup.
While a nascent space, synthetic data has recently attracted the attention of investors and as a result MOSTLY is competing with some impressive players like Datagen and Gretel.ai. However its chief concern will be the entrance of the big tech firms like NVIDIA. MOSTLY’s expert team, with good product-market fit, will still be confident that they have the tools to win this market.
Kirsty
Company Specialist at Welcome to the Jungle
Jan 2022
$25m
SERIES B
Mar 2020
$5.1m
SERIES A
This company has top investors
Michael Platzer
(CSO & Co-Founder)Michael co-founded MOSTLY AI in 2017 and led the company as CEO until 2020. Data scientist who held leading positions at Microsoft and Nokia. Awarded with the Global Marketing Research Award by the American Marketing Association. Holds a PhD degree from the Vienna University of Economics and Business and a Master degree from the Vienna University of Technology.
Roland Boubela
(Co-Founder)Previously a Data Scientist at Hutchison Drei Austria GmbH and Researcher at Medical University of Vienna.